Listed Company

Polynovo Ltd (ASX PNV)

Polynovo is an Australian company founded in 1998 by spinning off projects originating from the CSIRO. PNV is an Australian healthcare equipment and services company that designs and develops equipment for the treatment of burns, surgical wounds and Negative Pressure Wound Therapy and operates in Australia and has a global reach. The company headquarters are in Melbourne, Australia and it's shares trade publicly on the ASX.

Followers 163
Exchange ASX
Sector Healthcare
Industry Health Care Equipment & Services

Frequently Asked Questions

Featuring answers to some of the most frequent questions asked by investors about Polynovo Ltd
Company History
Was Polynovo created by the CSIRO?
PolyNovo Biomaterials was formed in 2004, as a joint venture between CSIRO and Xceed Biotechnology. The CSIRO continues to support the spin off company to further advance materials and device development programs through collaborative research schemes and consulting services.
Does Polynovo (PNV) pay dividends?
No, Polynovo Ltd (PNV) does not have a history of paying dividends.
Purchase Shares
Where can I buy Polynovo (PNV) shares?
An individual can buy and sell shares with the assistance of a broker who is licensed to trade on the ASX (Australian Securities Exchange).

Covering Polynovo Ltd

Mathan Somasundaram
Deep Data Analytics
Kym Sheehan
The Executive Remuneration Reporter
Stuart Roberts
Pitt Street Research and NDF Research
Tim Boreham
Independent Investment Research
Rob Tucker
Chester High Conviction Fund
Patrick Poke
Livewire Markets

Polynovo Ltd (ASX:PNV) is an Australian publicly listed company that trades on the Australian Stock Exchange. The company's stock code is PNV. Livewire Markets has 20 experts who have published 36 articles that have featured Polynovo Ltd. You can view all those wires here. The last time time PNV was featured was on the 05 August 2022 by Bell Potter in the wire “Bell Potter reporting season calendar August 2022”.